(Q42907840)

10 November 2017

title

A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers (English)

1 reference

amyotrophic lateral sclerosis

10 November 2017

main subject

1 reference

1 reference

Todd D Levine

1

1 reference

10 November 2017

Robert Bowser

series ordinal

2

1 reference

10 November 2017

Nicole Hank

series ordinal

3

1 reference

10 November 2017

David Saperstein

series ordinal

4

1 reference

10 November 2017

publication date

14 September 2010

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

10 November 2017

published in

1 reference

10 November 2017

volume

11

1 reference

10 November 2017

issue

6

1 reference

10 November 2017

page(s)

514-519

1 reference

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Longitudinal stability of CSF tau levels in Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.513052

10.3109/17482968.2010.513052

21 January 2018

Identifiers

DOI

1 reference

10 November 2017

1 reference